Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14235
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nusuetrong P. | |
dc.contributor.author | Sotanaphun U. | |
dc.contributor.author | Tep-Areenan P. | |
dc.date.accessioned | 2021-04-05T03:33:42Z | - |
dc.date.available | 2021-04-05T03:33:42Z | - |
dc.date.issued | 2012 | |
dc.identifier.issn | 1252208 | |
dc.identifier.other | 2-s2.0-84876900461 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/14235 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876900461&partnerID=40&md5=c7096cb25f8a0bce0bfd8e5550767525 | |
dc.description.abstract | The aim of the present study is to investigate the effect of standardized Phikud Navakot extract (NVKE) on aortic rings from male Sprague Dawley rats. Changes in tension were measured using an isometric force transducer and recorded on the PowerLab recording system. Vasorelaxant effect of NVKE was examined in the presence of indomethacin (10 microM), NG-nitro L-arginine methyl ester (L-NAME, 300 microM), methoxamine (0.1-300 microM), carbachol (1 nanoM-30 microM), or sodium nitroprusside (0.1 nanoM-10 microM). The results showed that NVKE (1-300 microg/mL) caused vasorelaxation in a concentration-dependent manner with a pEC50 value of 4.27 + 0.24 and R max of 67.7 + 13.9%. Pretreatment with indomethacin or L-NAME did not affect NVKE-induced vasorelaxation. However, co-incubation of indomethacin and L-NAME significantly reduced (p < 0.05) vasorelaxation to NVKE (100 microg/mL). Pre-treatment with NVKE significantly decreased (p < 0.05) endothelium-dependent relaxations to carbachol (Rmax = 52.90 + 14.3%), but not to sodium nitroprusside. Moreover, contractions to methoxamine were unaffected after pretreatment with NVKE. The present study suggested that NVKE decreased vasorelaxation to carbachol in the rat aorta, which may exert at least against muscarinic receptors. These findings support the use of Phikud Navakot, a major ingredient of Yahom Navakot, against dizziness and fainting. | |
dc.subject | carbachol | |
dc.subject | indometacin | |
dc.subject | methoxamine | |
dc.subject | nitric oxide synthase | |
dc.subject | nitroprusside sodium | |
dc.subject | Phikud Navakot extract | |
dc.subject | plant extract | |
dc.subject | prostaglandin synthase inhibitor | |
dc.subject | unclassified drug | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | article | |
dc.subject | concentration response | |
dc.subject | controlled study | |
dc.subject | herbal medicine | |
dc.subject | male | |
dc.subject | nonhuman | |
dc.subject | rat | |
dc.subject | thoracic aorta | |
dc.subject | vascular ring | |
dc.subject | vasodilatation | |
dc.subject | Analysis of Variance | |
dc.subject | Animals | |
dc.subject | Aorta, Thoracic | |
dc.subject | Carbachol | |
dc.subject | Drug Combinations | |
dc.subject | Endothelium, Vascular | |
dc.subject | Indomethacin | |
dc.subject | Male | |
dc.subject | Methoxamine | |
dc.subject | NG-Nitroarginine Methyl Ester | |
dc.subject | Nitroprusside | |
dc.subject | Plant Extracts | |
dc.subject | Rats | |
dc.subject | Rats, Sprague-Dawley | |
dc.subject | Transducers | |
dc.subject | Vasodilation | |
dc.subject | Vasodilator Agents | |
dc.title | Effects of Phikud Navakot extract on vascular reactivity in the isolated rat aorta | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Journal of the Medical Association of Thailand. Vol 95, No.SUPPL.12 (2012), p.S1-S7 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.